Peripheral intravenous catheter market Forecast 2026-2036: Market to Reach USD 14.89 billion by 2036 at 7.1% CAGR

NEWARK, DE | The peripheral intravenous catheter market stood at USD 7.0 billion in 2025 and is projected to expand significantly over the coming decade. Future Market Insights forecasts the global peripheral intravenous catheter market will reach USD 7.50 billion in 2026 and climb to USD 14.89 billion by 2036, reflecting a steady CAGR of 7.1% through the forecast period. This sustained expansion underscores the critical role of advanced safety-engineered devices in modern vascular access, as healthcare systems worldwide prioritize reduced needlestick injuries, lower bloodstream infection rates, and improved patient outcomes through innovations in catheter design and materials.

Read Full Report:https://www.futuremarketinsights.com/reports/peripheral-intravenous-catheter-market

Market snapshot: global market 2026 - 2036

Market size in 2026? USD 7.50 billion
Market size in 2036? USD 14.89 billion
CAGR (2026-2036)? 7.1%
Leading product segment(s) and shares? Short peripheral IV catheters lead, accounting for 35.1% share in 2025 due to dominance in routine short-term IV therapy
Leading technology and share? Safety PIVC leads at 30.3% share, reflecting regulatory compliance and healthcare worker protection priorities
Leading end use and share? Hospitals dominate at 54.6% share, driven by high patient volumes and complex treatment needs
Key growth regions? Asia Pacific leads growth through hospital infrastructure expansion and increasing procedure volumes; North America maintains leadership in revenue via premium technology adoption
Top companies? Becton, Dickinson and Company, B. Braun Melsungen AG, Smiths Group Plc., Terumo Corporation, Venner Medical, Vygon, Teleflex Incorporated, C. R. Bard, Inc., NIPRO Medical Corporation, Argon Medical Devices, Inc.

Market Momentum (YoY Path)

The peripheral intravenous catheter market exhibits consistent year-over-year progression driven by ongoing adoption of safety technologies and infection prevention features. Starting from USD 7.0 billion in 2025, the market advances to USD 7.50 billion in 2026. Momentum continues with further gains through 2028 and 2030 as regulatory frameworks and clinical evidence support upgrades to closed systems and antimicrobial surfaces. By 2031, expansion accelerates amid broader penetration in high-growth regions, leading to stronger increases toward 2033. The trajectory peaks with robust absolute dollar growth approaching USD 14.89 billion by 2035 and into 2036, delivering an absolute dollar increase of USD 7.39 billion between 2026 and 2036.

Why the Market is Growing

Growth in the peripheral intravenous catheter market stems from rising global hospitalization rates fueled by aging populations, higher chronic disease prevalence, and increased surgical procedure volumes that demand reliable vascular access. Regulatory mandates for safety-engineered devices, rooted in frameworks like the 2000 Needlestick Safety and Prevention Act and extended through state-level legislation, continue to drive adoption. Heightened awareness of catheter-associated bloodstream infections accelerates the shift toward antimicrobial-coated and closed system catheters that minimize complications and support better clinical outcomes.

Segment Spotlight

Product Type Short peripheral IV catheters maintain leadership with a 35.1% share, owing to their widespread use in routine short-term IV therapy across healthcare settings, ease of insertion, and cost-effectiveness for the majority of hospital admissions. Innovations such as integrated closed systems with pre-attached extension tubes and needleless connectors reduce blood exposure risks while preserving the practicality of short catheters.

Technology Safety PIVC holds a 30.3% share as facilities emphasize protection against needlestick injuries and blood exposure. Passive safety mechanisms that activate automatically, combined with antimicrobial coatings and blood control features in closed systems, address both clinician safety and infection prevention priorities.

End Use Hospitals command a 54.6% share due to concentrated patient volumes, complex regimens, and procurement capacity for premium safety devices. Infection control committees and group purchasing organizations further reinforce adoption of advanced technologies in this setting.

Drivers, Opportunities, Trends, Challenges

Drivers The legacy of the 2000 Needlestick Safety and Prevention Act, reinforced by legislation in 38 U.S. states and similar mandates globally, sustains demand for safety-engineered devices. Evolving infection control guidelines, including strengthened CDC recommendations for antimicrobial and closed system catheters, directly shape hospital purchasing.

Opportunities Extended dwell catheters that support seven- to fourteen-day use reduce insertion frequency, patient discomfort, and clinician workload while increasing per-catheter value. Manufacturers can capitalize by developing clinical evidence packages that demonstrate reduced complications and total cost-of-care savings.

Trends The market bifurcates between price-driven conventional catheters for low-risk uses and premium safety catheters featuring integrated closed systems, antimicrobial surfaces, and advanced polyurethane materials that soften at body temperature to minimize vessel irritation.

Challenges Margin compression affects standard catheters under centralized group purchasing, while advanced products require investment in clinician training and randomized trials to validate complication reduction claims and secure preferred procurement status.

Country Growth Outlook (CAGR)

India: 7.5%
United States: 7.5%
China: 7.0%
Italy: 6.7%
Germany: 6.2%
United Kingdom: 5.9%
(Note: Japan at 5.5% also noted in source regional context)
Competitive Landscape The peripheral intravenous catheter market remains consolidated, led by Becton, Dickinson and Company, B. Braun Melsungen AG, and Smiths Group Plc. Terumo Corporation, Teleflex Incorporated, and NIPRO Medical Corporation hold strong regional and specialized positions. Competition centers on integrated safety systems, antimicrobial performance, clinical evidence, and comprehensive education programs that support implementation and reduce device failure rates.

Subscribe for Year-Round Insights → Stay ahead with quarterly and annual data updates: https://www.futuremarketinsights.com/reports/brochure/rep-gb-2558

Get Access of Report Sample:https://www.futuremarketinsights.com/reports/sample/rep-gb-2558

Scope of the Report

Quantitative Units: Market value in USD (USD 7.50 billion in 2026 to USD 14.89 billion in 2036 at a CAGR of 7.1%)
Market Definition: Global production and supply of medical devices inserted into peripheral veins for fluid, medication, blood product administration, and blood sampling, made from medical-grade polymers with safety features
Segmentation: Product Type (Short Peripheral IV Catheter, Integrated/Closed Peripheral IV Catheter, Others); Technology (Safety PIVC, Conventional PIVC); End User (Hospitals, Clinics, Ambulatory Surgical Centers, Others); Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
Countries Covered: United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, India, Japan, South Korea, Brazil, and 40+ others
Key Companies Profiled: Becton, Dickinson and Company, B. Braun Melsungen AG, Smiths Group Plc., Terumo Corporation, Venner Medical, Vygon, Teleflex Incorporated, C. R. Bard, Inc., NIPRO Medical Corporation, Argon Medical Devices, Inc.

FAQ

What is the projected size of the peripheral intravenous catheter market in 2036? The peripheral intravenous catheter market is expected to reach USD 14.89 billion by 2036.

What CAGR is forecasted for the peripheral intravenous catheter market from 2026 to 2036? Future Market Insights projects a 7.1% CAGR during the period.

Which product type holds the leading share? Short peripheral IV catheters account for 35.1% of the market share due to their role in routine short-term IV therapy.

Which technology segment leads demand? Safety PIVC leads with a 30.3% share, driven by regulatory and protection priorities.

Which end user dominates the market? Hospitals represent 54.6% of demand, supported by high volumes and procurement strength.

Which countries show the highest growth rates? India and the United States both project 7.5% CAGR, followed by China at 7.0%.

Explore More Related Studies Published by FMI Research:

Radiology Drainage Catheters Market: https://www.futuremarketinsights.com/reports/radiology-drainage-catheters-market

Digital Health for Obesity Market: https://www.futuremarketinsights.com/reports/digital-health-for-obesity-market

Companion Animal Imaging Market: https://www.futuremarketinsights.com/reports/companion-animal-imaging-market

PARP Inhibitor Market: https://www.futuremarketinsights.com/reports/parp-inhibitors-market

Demand for Stent Graft Balloon Catheter in Japan: https://www.futuremarketinsights.com/reports/japan-stent-graft-balloon-catheter-market

Why FMI: Decisions that Change Outcomes- https://www.futuremarketinsights.com/why-fmi

Have a specific Requirements and Need Assistant on Report Pricing or Limited Budget please contact us - sales@futuremarketinsights.com

Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

About Future Market Insights (FMI)

Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.

This release was published on openPR.